BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38560509)

  • 1. Neuroleptic malignant syndrome after overdose of haloperidol - A case report.
    Kraaijvanger N; Mieloo T
    Toxicol Rep; 2024 Jun; 12():356-360. PubMed ID: 38560509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to benzodiazepines and the clinical course in malignant catatonia associated with schizophrenia: A case report.
    Ohi K; Kuwata A; Shimada T; Yasuyama T; Nitta Y; Uehara T; Kawasaki Y
    Medicine (Baltimore); 2017 Apr; 96(16):e6566. PubMed ID: 28422845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examining the Features of Neuroleptic Malignant Syndrome in Anti-NMDA Receptor Encephalitis: A Case-Control Study.
    Ramirez-Bermudez J; Restrepo-Martinez M; Espinola-Nadurille M; Martinez-Angeles V; Lopez-Hernandez JC; Hernandez-Vanegas LE; Martinez-Carrillo F; Ruiz-Garcia R; Rivas-Alonso V; Flores-Rivera J; Pollak TA
    J Acad Consult Liaison Psychiatry; 2024; 65(3):222-230. PubMed ID: 38151160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up].
    Askenazy F; Dor E; Benoit M; Dupuis G; Serret S; Myquel M; Seddiki Y
    Encephale; 2010 Feb; 36(1):46-53. PubMed ID: 20159196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ziprasidone- and lithium-induced neuroleptic malignant syndrome.
    Borovicka MC; Bond LC; Gaughan KM
    Ann Pharmacother; 2006 Jan; 40(1):139-42. PubMed ID: 16352776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroleptic malignant syndrome secondary to olanzapine, a presentation with severe acute kidney injury requiring hemodialysis: a case report.
    Chang CK; Payus AO; Noh MM; Lansing MG; Sumpat D; Lu SJA; Yew BT
    J Med Case Rep; 2022 Oct; 16(1):366. PubMed ID: 36203196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroleptic malignant syndrome associated with the use of prochlorperazine in a patient with a recent history of antipsychotic-induced neuroleptic malignant syndrome.
    Musselman ME; Browning LA; Parker D; Saely S
    Ann Pharmacother; 2011 Nov; 45(11):e61. PubMed ID: 21972252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic malignant syndrome due to olanzapine.
    Hall KL; Taylor WH; Ware MR
    Psychopharmacol Bull; 2001; 35(3):49-54. PubMed ID: 12397878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroleptic Malignant Syndrome From Oxcarbazepine and Topiramate Withdrawal: An Unusual Case.
    Dang S; Peteru S; Raja M; Askandaryan A; Vallejo G
    Cureus; 2022 Oct; 14(10):e29992. PubMed ID: 36381714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The management challenges of a case with Flupentixol-induced neuroleptic malignant syndrome.
    Elyasi F; Sadati S; Heydari F
    Neuropsychopharmacol Rep; 2023 Mar; 43(1):154-159. PubMed ID: 36585735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroleptic malignant syndrome versus serotonin syndrome: the search for a diagnostic tool.
    Sokoro AA; Zivot J; Ariano RE
    Ann Pharmacother; 2011 Sep; 45(9):e50. PubMed ID: 21878660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe Recurrence of Neuroleptic Malignant Syndrome: Usefulness of Dexmedetomidine for Antipsychotic Withdrawal.
    Maeda K; Ichiba T; Kashiwa K; Okazaki Y
    Cureus; 2023 Oct; 15(10):e47088. PubMed ID: 38022067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prolonged neuroleptic malignant syndrome after Haloperidol injection].
    Wystub N; Heymel S; Fritzenwanger M; Schulze PC; Pfeifer R
    Med Klin Intensivmed Notfmed; 2018 Apr; 113(3):212-216. PubMed ID: 28752347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroleptic malignant syndrome: case report and discussion.
    Chandran GJ; Mikler JR; Keegan DL
    CMAJ; 2003 Sep; 169(5):439-42. PubMed ID: 12952806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroleptic rechallenge after neuroleptic malignant syndrome: case report and literature review.
    Wells AJ; Sommi RW; Crismon ML
    Drug Intell Clin Pharm; 1988 Jun; 22(6):475-80. PubMed ID: 2899492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diazepam-responsive malignant catatonia in a patient with an initial clinical diagnosis of neuroleptic malignant syndrome: a case report].
    Mishima T; Tsuboi Y; Higuchi MA; Tsugawa J; Obata T; Yamada T
    Brain Nerve; 2011 May; 63(5):503-7. PubMed ID: 21515931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Case report: Neuroleptic malignant syndrome and diagnostic difficulties].
    Khouri C; Planès S; Logerot S; Villier C; Mallaret M
    Encephale; 2016 Jun; 42(3):277-80. PubMed ID: 26923996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical Neuroleptic Malignant Syndrome Precipitated by Clozapine and Quetiapine Overdose: A Diagnostic Challenge.
    Teo DCL; Wong HK; Tan SN
    Innov Clin Neurosci; 2018; 15(7-8):20-22. PubMed ID: 30254795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroleptic malignant syndrome in pregnancy: case report and literature review.
    Escobar-Vidarte MF; Loaiza-Osorio S; Messa AA; Macías GE
    J Matern Fetal Neonatal Med; 2019 Jul; 32(14):2438-2441. PubMed ID: 29363376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reconsidering Rigidity in the Diagnosis of Neuroleptic Malignant Syndrome: A Case Report.
    El Khoury R; Kassab A; Dagher R; Javelot H; El Chammay R; Richa S
    J Psychiatr Pract; 2020 Jul; 26(4):320-323. PubMed ID: 32692129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.